1.Message from the Editor-in-Chief: Theranostic Imaging in 2018
Nuclear Medicine and Molecular Imaging 2018;52(2):87-88
No abstract available.
Theranostic Nanomedicine
2.Contribution of Radionuclide Theranostics for Managing Intractable Malignancies
Nuclear Medicine and Molecular Imaging 2018;52(3):168-169
No abstract available.
Theranostic Nanomedicine
3.Nuclear Theranostics in Asia: In vivo Companion Diagnostics
Nuclear Medicine and Molecular Imaging 2019;53(1):1-6
No abstract available.
Asia
;
Friends
;
Humans
;
Theranostic Nanomedicine
4.Nuclear Theranostics in Indonesia: Past, Present, and Future
Nuclear Medicine and Molecular Imaging 2019;53(1):33-34
Nuclear medicine in Indonesia has a quite long history since the late 1960s. There are some problems and obstacles that have to be solved and overcome in order to develop nuclear medicine services, spread the services to reach every target area, and implement new novel therapeutic nuclear medicine as well. The right strategy and strong effort should be performed for a successful result. Theranostics nuclear medicine will play a more prominent role in the management of cancer patients.
Humans
;
Indonesia
;
Nuclear Medicine
;
Theranostic Nanomedicine
5.Review: optically-triggered phase-transition droplets for photoacoustic imaging.
Qiyang CHEN ; Jaesok YU ; Kang KIM
Biomedical Engineering Letters 2018;8(2):223-229
Optically-triggered phase-transition droplets have been introduced as a promising contrast agent for photoacoustic and ultrasound imaging that not only provide significantly enhanced contrast but also have potential as photoacoustic theranostic molecular probes incorporated with targeting molecules and therapeutics. For further understanding the dynamics of optical droplet vaporization process, an innovative, methodical analysis by concurrent acoustical and ultrafast optical recordings, comparing with a theoretical model has been employed. In addition, the repeatability of the droplet vaporization-recondensation process, which enables continuous photoacoustic imaging has been studied through the same approach. Further understanding the underlying physics of the optical droplet vaporization and associated dynamics may guide the optimal design of the droplets. Some innovative approaches in preclinical studies have been recently demonstrated, including sono-photoacoustic imaging, dual-modality of photoacoustic and ultrasound imaging, and super-resolution photoacoustic imaging. In this review, current development of optically triggered phase-transition droplets and understanding on the vaporization dynamics, their applications are introduced and future directions are discussed.
Methods
;
Models, Theoretical
;
Molecular Probes
;
Theranostic Nanomedicine
;
Ultrasonography
;
Volatilization
6.Radio-graphene in Theranostic Perspectives
Nuclear Medicine and Molecular Imaging 2017;51(1):17-21
Owing to its unique physicochemical properties such as high surface area, notable biocompatibility, robust mechanical strength, high thermal conductivity, and ease of functionalization, 2D-layered graphene has received tremendous attention as a futuristic nanomaterial and its-associated research has been rapidly evolving in a variety of fields.With the remarkable advances of graphene especially in the biomedical realm, in vivo evaluation techniques to examine in vivo behavior of graphene are largely demanded under the hope of clinical translation. Many different types of drugs such as the antisense oligomer and chemotherapeutics require optimal delivery conveyor and graphene is now recognized as a suitable candidate due to its simple and high drug loading property. Termed as ‘ radio-graphene’, radioisotope-labeled graphene approach was recently harnessed in the realm of biomedicine including cancer diagnosis and therapy, contributing to the acquisition of in vivo information for targeted drug delivery. In this review, we highlight current examples for bioapplication of radiolabeled graphene with brief perspectives on future strategies in its extensive bio- or clinical applications.
Diagnosis
;
Graphite
;
Hope
;
Nanostructures
;
Theranostic Nanomedicine
;
Thermal Conductivity
7.Nuclear Medicine Theranostics: Perspective from Pakistan
Humayun BASHIR ; M Numair YOUNIS ; M Rehan GUL
Nuclear Medicine and Molecular Imaging 2019;53(1):38-41
Nuclear medicine has been offering diagnostic and therapeutic solution since the introduction of radioactive iodine for thyroid diseases since decades. However, the concept of theranostics has given a new found impetus to the use of pairs of radiopharmaceuticals for diagnosis and treatment. Presented here is a perspective on theranostics from Pakistan.
Diagnosis
;
Iodine
;
Nuclear Medicine
;
Pakistan
;
Radiopharmaceuticals
;
Theranostic Nanomedicine
;
Thyroid Diseases
8.Perspectives for Concepts of Individualized Radionuclide Therapy, Molecular Radiotherapy, and Theranostic Approaches
Nuclear Medicine and Molecular Imaging 2019;53(3):167-171
Radionuclide therapy (RNT) stands on the delivery of radiation to tumors or non-tumor target organs using radiopharmaceuticals that are designed to have specific affinity to targets. RNT is recently called molecular radiotherapy (MRT) by some advocators in order to emphasize its characteristics as radiotherapy and the relevance of dosimetry-guided optimization of treatment. Moreover, RNT requires relevant radiation protection standards because it employs unsealed radionuclides and gives therapeutic radiation doses in humans. On the basis of these radiation protection standards, the development and use of radiopharmaceuticals for combined application through diagnostics and therapeutics lead to theranostic approaches that will enhance the efficacy and safety of treatment by implementing dosimetry-based individualization.
Humans
;
Radiation Protection
;
Radioisotopes
;
Radiopharmaceuticals
;
Radiotherapy
;
Theranostic Nanomedicine
9.Analytical Performance of Bio-Rad D-100 on a Hemoglobin A1c Assay.
Changseung LIU ; Eunhye CHOI ; In Cheol BAE ; Sang Guk LEE ; Jeong Ho KIM
Laboratory Medicine Online 2017;7(2):59-65
BACKGROUND: Hemoglobin A1c (HbA1c) is considered a marker useful for the follow-up and diagnosis of diabetes and implies the importance of reliable assay methods that are traceable to a reference method. We evaluated analytical performance of a new high-performance liquid chromatography system for the HbA1c assay: D-100 from Bio-Rad Laboratories (USA). METHODS: We evaluated precision, linearity, and carry-over of D-100, according to the Clinical and Laboratory Standards Institute's guidelines. Comparative analysis of D-100 with Integra 800 (Roche Diagnostics, Germany) and Capillarys 3 (Sebia, France) was conducted. Additionally, we evaluated the throughput of the three instruments. RESULTS: Precision of low- and high-concentration controls in D-100 showed a CV of less than 1%. The linearity was excellent (R²=0.999) in the range of 3.51-18.7%, and carry-over was not observed. HbA1c results of D-100 (n=144) showed good correlation with those of Integra 800 (r=0.993) and Capillarys 3 (r=0.996). The % bias between D-100 and Integra 800 or Capillarys 3 was within the allowable range at all 3 medical decision levels (5.7%, 6.5%, and 10.0%). Elapsed time in the analysis of the first sample by D-100 was shorter than that of Integra 800 (2.4 vs. 11.1 minutes), but subsequent samples took more time (0.8 vs. 0.3 minutes per sample). CONCLUSIONS: D-100 showed reliable analytical performance with good precision and linearity, minimal carry-over, and acceptable comparative characteristics relative to other instruments. D-100 is expected to be useful for clinical measurements of HbA1c for diabetes diagnosis and theranostics.
Bias (Epidemiology)
;
Chromatography, Liquid
;
Diagnosis
;
Follow-Up Studies
;
Methods
;
Theranostic Nanomedicine
10.Multimodal Composite Iron Oxide Nanoparticles for Biomedical Applications
Shameer PILLARISETTI ; Saji UTHAMAN ; Kang Moo HUH ; Yang Seok KOH ; Sangjoon LEE ; In Kyu PARK
Tissue Engineering and Regenerative Medicine 2019;16(5):451-465
BACKGROUND: Iron oxide nanoparticles (IONPs) are excellent candidates for biomedical imaging because of unique characteristics like enhanced colloidal stability and excellent in vivo biocompatibility. Over the last decade, material scientists have developed IONPs with better imaging and enhanced optical absorbance properties by tuning their sizes, shape, phases, and surface characterizations. Since IONPs could be detected with magnetic resonance imaging, various attempts have been made to combine other imaging modalities, thereby creating a high-resolution imaging platform. Composite IONPs (CIONPs) comprising IONP cores with polymeric or inorganic coatings have recently been documented as a promising modality for therapeutic applications. METHODS: In this review, we provide an overview of the recent advances in CIONPs for multimodal imaging and focus on the therapeutic applications of CIONPs. RESULTS: CIONPs with phototherapeutics, IONP-based nanoparticles are used for theranostic application via imaging guided photothermal therapy. CONCLUSION: CIONP-based nanoparticles are known for theranostic application, longstanding effects of composite NPs in in vivo systems should also be studied. Once such issues are fixed, multifunctional CIONP-based applications can be extended for theranostics of diverse medical diseases in the future.
Colloids
;
Iron
;
Magnetic Resonance Imaging
;
Multimodal Imaging
;
Nanoparticles
;
Optical Imaging
;
Polymers
;
Theranostic Nanomedicine
;
Ultrasonography